দেশ: দক্ষিণ আফ্রিকা
ভাষা: ইংরেজি
সূত্র: South African Health Products Regulatory Authority (SAHPRA)
Bm_squib
VAGMYCIN VAGINAL CREAM SCHEDULING STATUS: S4 PP ZIMBABWE PROPRIETARY NAME (and dosage form) VAGMYCIN VAGINAL CREAM COMPOSITION VAGMYCIN VAGINAL CREAM: Amphotericin B : 50 mg activity/4 g. Tetracycline base: 100 mg tetracycline hydrochloride activity/4 g. Preservatives: Methylparaben 0,228%; propylparaben 0,0228%. PHARMACOLOGICAL CLASSIFICATION: Category A 18.6 Vaginal Preparations. PHARMACOLOGICAL ACTION VAGMYCIN combines a broad spectrum antibiotic with an anti-fungal agent having activity against a wide variety of fungi and yeasts. These products have been designed to provide simultaneous antibacterial, antimonilial and antitrichomonal therapy. Tetracycline has proved effective therapeutically against infections caused by a broad spectrum of micro-organisms including both gram- positive and gram-negative bacteria, spirochaetes, certain rickettsiae and viruses. While the direct action of tetracycline against trichomonas in vitro is slight, it acts against the bacteria with which trichomonas often exists in symbiosis in vivo. Amphotericin B is an antifungal antibiotic with specific activity against Candida albicans. It has a broad spectrum of activity against filamentous fungi, yeast-like fungi and dermatophytes. INDICATIONS Indicated in the treatment of candidal, trichomonal, and/or mixed bacterial vaginitis. These preparations are also useful in the treatment of infective complications of atrophic or senile vaginitis, in non-specific vaginitis, and in vaginal infections in which an offending organism cannot be identified. Among the most common vaginal infections are Candida albicans and Trichomonas vaginalis. Candidal infections of the vagina are being reported with increasing frequency in women on oral antibacterial agents and during oral contraceptive therapy. Additional factors that increase su সম্পূর্ণ নথি পড়ুন